NFKB1 and carcinoma: The phenotype with the pharmacological inhibitors demonstrates that the NF-kB pathway is important for proliferation of cisplatin treated oral carcinoma cells adherent to carcinoma matrix and NF-kB is important for proliferation of talin deficient cells treated with cisplatin.